Shave biopsy okay for initial staging of malignant melanoma
Shave biopsies may potentially hamper accurate diagnosis and staging of melanoma, but a study indicates that they are reasonably safe and accurate for the initial evaluation of the disease.
Diagnosis & Disease Information
Topical treatment for melanoma prevention in the works
A cancer-fighting formulation applied directly to the skin to prevent the development of melanoma lesions is now under study in the laboratory—and demonstrating encouraging results.
Autoimmune vitiligo may help fight melanoma
Inducing vitiligo in persons with melanoma might enhance the natural immune response of these patients, according to data yielded by a recent study.
Blood biomarkers may foretell melanoma metastasis risk
The identification of several plasma biomarkers that appear to predict the risk of metastasis in melanoma could lead to more convenient and less costly monitoring of persons with this cancer.
Overall cancer mortality rates decrease, but incidence of some cancers increases
Overall, cancer incidence rates fell approximately 1% annually and overall death rates decreased by an average of 1.6% annually between 2003 and 2007.
Small target for melanoma eradication gets big results
Immune cells targeting just two cancer-related proteins in melanoma cells largely shrunk the tumors and kept the melanoma at bay for more than 36 weeks post-injection.
Cancer costs will reach or exceed $158 billion in 2020
If the US population ages at the rate predicted by the US Census Bureau and cancer incidence, survival rates, and costs remain stable, in the year 2020 direct cancer care expenditures will reach $157.77 billion in 2010 dollars.
Gene deletion may explain many cases of glioblastoma
An important gene deletion appears to occur in as many as 1 of every 4 cases of glioblastoma—the most common adult brain cancer—scientists have found.
COX-2 inhibitor may protect against some skin cancers
Celecoxib (Celebrex) may ward off squamous and basal cell carcinomas in persons with extensive actinic damage who are at high risk for developing nonmelanoma skin cancers.
Study demonstrates drug’s effectiveness for treating metastatic melanoma
Patients with metastatic cancer who are treated with ipilimumab experience improved survival, according to a study published in the New England Journal of Medicine.
- Loading...
Loading...
Loading... 
Loading...